VCU/Old Dominion University study finds CD97 gene expression and function correlate with WT1 protein expression

VCU/Old Dominion University study finds CD97 gene expression and function correlate with WT1 protein expression Researchers at Virginia Commonwealth University Medical Center’s VCU Massey Cancer Center and Harold F. Young Neurosurgical Center (Richmond, VA) and Old Dominion University (Norfolk, VA) have discovered that suppression of Wilms tumor 1 protein (WT1) results in downregulation of CD97 … Continue reading “VCU/Old Dominion University study finds CD97 gene expression and function correlate with WT1 protein expression”

VCU/Old Dominion University study finds CD97 gene expression and function correlate with WT1 protein expression

Researchers at Virginia Commonwealth University Medical Center’s VCU Massey Cancer Center and Harold F. Young Neurosurgical Center (Richmond, VA) and Old Dominion University (Norfolk, VA) have discovered that suppression of Wilms tumor 1 protein (WT1) results in downregulation of CD97 gene expression in three glioblastoma cell lines and reduces the characteristic invasiveness exhibited by glial tumor cells. Although further studies must be performed, the authors propose that CD97 may prove to be a new target for anti-glioma therapies.

Click here to read the full press release

                                        ###

 

 

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply